Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

NCT01458301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

487

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Placebo
DRUG: TAK-385
DRUG: TAK-385
DRUG: TAK-385
DRUG: Leuprorelin acetate

Sponsor

Takeda